← Eichor
Condition: Fibrotic Interstitial Lungs Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fibrotic Interstitial Lungs Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Phase N/A · 2 location(s) · Erasmus Medical Center · NCT04304898Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
NA · 1 location(s) · State University of New York at Buffalo · NCT07512687Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Phase 2 · 1 location(s) · University of Alberta · NCT06053164Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial
NA · 1 location(s) · Hospital de Granollers · NCT07482917RCT of Nintedanib in Fibrotic Sarcoidosis
Phase 4 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06479603Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
NA · 1 location(s) · Hospital de Granollers · NCT07486206Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) P
Phase 3 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07613099Taiwan Interstitial Lung Disease Multi-center Investigation and Registry
Phase N/A · 1 location(s) · Taichung Veterans General Hospital · NCT06476470Physical Activity and Fibrosing Interstitial Lung Disease
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06182748A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Ant
Phase N/A · 1 location(s) · Royal Brompton & Harefield NHS Foundation Trust · NCT07332117Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Phase 2 · 1 location(s) · Erasme University Hospital · NCT06189820Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Phase 2 · 5 location(s) · Vejle Hospital · NCT06714123Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)
NA · 2 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07457463Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
NA · 4 location(s) · Mayo Clinic · NCT06751069Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease
NA · 2 location(s) · University of British Columbia · NCT04299945Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREAT
NA · 1 location(s) · King's College Hospital NHS Trust · NCT06326957Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
Phase N/A · 1 location(s) · Dai Huaping · NCT06655090Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.
NA · 1 location(s) · Katerina M. Antoniou · NCT07466420
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.